We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
From 1 April, we're introducing the new role of Director of the Parkinson's Virtual Biotech alongside the existing role of Director of Research.
Date
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson's with levodopa-induced dyskinesias.
Date
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson's symptoms.
Date
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson's.
Date
Reach Your Peak will use the new physical activity grant funding to subsidise their online fitness and wellbeing sessions for the Parkinson's community.
Date
NICE has conditionally recommended 5 remote monitoring devices for Parkinson's for use in the NHS in England.
Date
This International Day of Women and Girls in Science we're celebrating some of the pioneering women who are driving Parkinson's research forward.
Date
A Lord's inquiry supported by Parkinson's UK has recommended the UK government urgently prioritises funding and support for clinical research.
Date
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson's.
Date
Parkinson's UK is helping more people with Parkinson's to stay active with a new physical activity grant for online fitness sessions. Neuro Heroes will use the grant funding to subsidise classes and help more people on their physical activity journey.